News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Clinical Data Highlighting Foundation Medicine's Next-Generation Sequencing Analysis in Breast Cancer to be Presented at SABCS



12/4/2012 10:49:42 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic analysis to routine clinical care, today announced that new data from its collaborations with multiple academic medical center research groups will be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) taking place December 4-8, 2012 in San Antonio, Texas. These presentations highlight Foundation Medicine’s targeted next-generation sequencing platform for comprehensive molecular profiling in cancer.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES